InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Keros Therapeutics, Inc.

KROS Clue Score73
United States Fiscal year ends December CIK 0001664710 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

11
Insider
Date
Role
Action
Shares
Price
Amount
Jean Jacques Bienaime
17 Aug 2026
Director
Buy
1,000
$10.27
$10.27K
Jean Jacques Bienaime
15 Jul 2026
Director
Buy
1,000
$10.61
$10.61K
Jean Jacques Bienaime
15 Jun 2026
Director
Buy
1,000
$10.19
$10.19K
Jean Jacques Bienaime
15 May 2026
Director
Buy
1,000
$10.58
$10.58K
Jean Jacques Bienaime
15 Apr 2026
Director
Buy
1,000
$11.70
$11.70K
Jean Jacques Bienaime
9 Mar 2026
Director
Buy
2,000
$11.21
$22.42K
ADAR1 Capital Management, LLC
9 Apr 2025
10% owner
Buy indirect
74,333
$10.33
$767.86K
ADAR1 Capital Management, LLC
9 Apr 2025
10% owner
Buy indirect
500,000
$10.33
$5.17M
ADAR1 Capital Management, LLC
9 Apr 2025
10% owner
Buy indirect
325,000
$9.86
$3.20M
ADAR1 Capital Management, LLC
9 Apr 2025
10% owner
Buy indirect
16,365
$9.40
$153.75K
ADAR1 Capital Management, LLC
9 Apr 2025
10% owner
Buy indirect
18,560
$9.40
$174.37K
Showing 250 of 403 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 174
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 14
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 72
Sales at will 274
Transactions with no price 0
Shares from compensation/vesting 18,653,788
Sales filed before the plan box existed 256
History held since 8 Apr 2020